Frankfurt - Delayed Quote EUR

IGM Biosciences, Inc. (1K0.F)

1.0100
+0.0250
+(2.54%)
As of 8:31:16 AM GMT+2. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,679
2,679
2,130
1,069
0
Operating Expense
211,259
211,259
265,591
229,025
165,323
Operating Income
-208,580
-208,580
-263,461
-227,956
-165,323
Net Non Operating Interest Income Expense
12,785
12,785
17,743
7,035
159
Other Income Expense
--
--
-20
-181
159
Pretax Income
-195,795
-195,795
-245,738
-221,102
-165,164
Tax Provision
0
0
678
0
0
Net Income Common Stockholders
-195,795
-195,795
-246,416
-221,102
-165,164
Diluted NI Available to Com Stockholders
-195,795
-195,795
-246,416
-221,102
-165,164
Basic EPS
-3.24
-3.24
-4.71
-5.32
-4.93
Diluted EPS
-3.24
-3.24
-4.71
-5.32
-4.93
Basic Average Shares
60,514.5460
60,514.5460
52,311.9580
41,543.9540
33,479.7820
Diluted Average Shares
60,514.5460
60,514.5460
52,311.9580
41,543.9540
33,479.7820
Total Operating Income as Reported
-208,580
-208,580
-263,461
-227,956
-165,323
Total Expenses
211,259
211,259
265,591
229,025
165,323
Net Income from Continuing & Discontinued Operation
-195,795
-195,795
-246,416
-221,102
-165,164
Normalized Income
-195,795
-195,795
-246,416
-221,102
-165,164
Interest Income
12,785
12,785
17,743
7,035
159
Net Interest Income
12,785
12,785
17,743
7,035
159
EBIT
-208,580
-208,580
-263,461
-227,956
-165,323
EBITDA
-199,468
-199,468
-255,184
-221,881
-160,839
Reconciled Depreciation
9,112
9,112
8,277
6,075
4,484
Net Income from Continuing Operation Net Minority Interest
-195,795
-195,795
-246,416
-221,102
-165,164
Normalized EBITDA
-199,468
-199,468
-255,184
-221,881
-160,839
Tax Rate for Calcs
0
0
0.0002
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 9/18/2019

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

HVE.F Innoviva, Inc.
15.90
-1.24%
 
6OP.F OSE Immunotherapeutics SA
5.98
-0.75%
 
UCBJY UCB SA
85.76
-0.24%
 
THRD Third Harmonic Bio, Inc.
5.15
0.00%
 
SRZN Surrozen, Inc.
6.50
-9.72%
 
ORKA Oruka Therapeutics, Inc.
9.71
+0.94%
 
ABVX ABIVAX Société Anonyme
6.10
+0.99%
 
ZURA Zura Bio Limited
1.1700
-3.31%
 
KRON Kronos Bio, Inc.
0.7250
-0.21%
 
FBRX Forte Biosciences, Inc.
7.60
+10.47%